AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2012

Aug 21, 2012

6990_dirs_2012-08-21_cfbf1943-2cc8-4a51-97de-107bda6aaca6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2012-08-17

Reporting Person: Aberman Zami (Director, CEO & Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-17	Common Stock	S	33853	$5	Disposed	1315298	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to automatic selling under Rule 10b5-1 trading plan adopted by the reporting person as amended on May 15, 2012.